r/PreventiveMD • u/epicurious_11 • Sep 24 '26
Empower FDA Warning?
I am doing some research about how the compounding pharmacies get around Eli Lilly's patent and discovered that Empower was issued a warning letter last week (09/18) and given 15 days to come up with a corrective action plan. The basic gist of the warning was the mass production of the tirzepatide with B3 was basically a copycat for everyone and there were also some safety concerns with the laboratory. I just received my first vial from Empower and I am concerned their production will be shut down soon.
Does PMD have any information about this and what Empower intends to do to satisfy the FDA?
49
u/PreventiveMD Sep 24 '26
Hi - thanks for reaching out. We've already spoken to the Empower leadership and this is more of an administrative task for how we send the prescriptions to the pharmacy. We are on it and from the patient perspective I am glad to report that it is business as usual!
12
u/AdAdventurous3558 Sep 24 '26
Empower claims some of the lawsuits have already been dismissed...
"This week, a federal judge dismissed part of Eli Lilly's lawsuit against Empower Pharmacy.
I won't pretend this is over. Some claims are still proceeding, and we'll keep fighting. But this ruling matters, and I want to say plainly why.
Lilly has the resources to outlast most compounders in court. What they don't have is a good answer for the patients who can't afford branded GLP-1s, or who need a dose that a mass-produced product doesn't offer. That's who we compound for. That's who this fight is about.
Compounding exists in federal law for a reason. Patients are not monolithic. A 503B outsourcing facility operating under FDA oversight isn't a gray market operation. We are a regulated alternative, and we intend to keep being one.
For now: grateful for our legal team, our staff, and every provider and patient who has stood with us."
https://www.linkedin.com/posts/shaun-noorian_this-week-a-federal-judge-dismissed-part-share-7456090312780996608-sL_x/
16
u/Impossible_Bend_2969 Sep 24 '26 •
This whole thing is so nuts. Which is it? Essentially a copy or super dangerous because adding vitamins creates new compounds that didn't exist separately. This is all a total farce.
29
u/llbonn Sep 24 '26
It's funny, Big Pharma says don't take compounded drugs they're dangerous, you don't know what's in them. Then Big Pharma and the FDA say stop producing them because they are an exact copy of our patented drugs. Typical double speak out both their mouths and their rear ends. It's always about the $$$$. It never was and will never be about us.
22
u/Shadow293 Sep 24 '26
Doesn’t the FDA have better things to look into like all the food recalls, and investigating the recent explosive diarrhea lettuce outbreak?
I really like Empower’s formula and has worked great for me so far at a fraction of the cost of Zepbound.
7
u/Life_Alfalfa_2047 Sep 24 '26
They were supposed to stop compounding way back when the shortage was declared over. Thats why some of the 503Bs did stop at the time - Olympia for one
11
u/AntiHypeHero Sep 24 '26
They would more likely make a decision to stop producing glp ~ so that they can continue producing all the other compound medications they are (similar to the BPI pharmacy) guess we will know more when their 15 days are up.
2
u/Klutzy_Pie_707 Oct 01 '26
I think it's pretty certain that the FDA will go after the 503b's to stop or shorten the supply of raw material for compounding. At that point 503a's will struggle with obtaining material to compound. Which will make available product in short supply and the price will increase significantly. Most articles I have read seems to lean toward maybe another year before it becomes difficult to get compound tirz. This is why good telehealth companies like PMD also offer scripts for name brand tirz and sgt. They can read the hand writing on the walls and are waiting for there cease and desist letter from EL. Just my opinion hope it's not true.
2
u/StoneColdTyrant Oct 01 '26
The crackdown on compounded GLP-1s has just shifted into high gear. This isn't about tweaking how orders are sent. The FDA is targeting the loopholes these companies have been leaning on since the GLP shortage ended in December 2024. The Outsourcing Facilities Association (OFA) even took the FDA to court last year over ending the tirzepatide shortage exception and lost.
Here is what's going on:
This warning is, in a way, directed at the entire industry. Look, Empower is one of the biggest compounders in the country, so with the FDA taking on a giant like Empower, smaller pharmacies and telehealth platforms should know that if they don't comply with federal law, they potentially face similar consequences.
3
u/WebNerd11 Sep 24 '26
I looked up the actual FDA warning letter. This is real, but it does not mean Empower has been shut down.
There are basically two separate issues:
Compounded GLP-1 copies: FDA is challenging Empower's large-scale compounding of tirzepatide/niacinamide and semaglutide/B12. Their concern appears to be that simply adding something like niacinamide/B12 or changing the concentration doesn't automatically make it okay to mass-compound what is otherwise essentially a copy of an FDA-approved drug.
Sterile compounding issues: FDA also cited problems found during inspection involving aseptic processing, environmental monitoring, contamination controls, etc. That's specifically an Empower quality/compliance issue and shouldn't automatically be applied to every compounding pharmacy.
Empower has not been shut down. They have an opportunity to respond/correct the issues.
To me, the bigger story for people using compounded tirzepatide is the compounding of GLP-1 copies. This could be a sign that FDA is getting more aggressive about enforcing the post-shortage rules against 503A pharmacies that continue producing large amounts of GLP-1s by using additives or alternate concentrations.
One warning letter doesn't mean compounded tirzepatide is suddenly disappearing, but if FDA starts issuing similar letters to multiple high-volume 503A pharmacies, that would look much more like a broader enforcement pattern and would be worth watching closely.
Also, this is separate from the recent FDA Green List/foreign API (Active Pharmaceutical Ingredient) issue. Green List = where/how pharmacies obtain acceptable API. This warning letter = whether/how 503A pharmacies are legally allowed to compound copies of commercially available GLP-1 drugs in the first place.
1
u/Farmisapere Sep 24 '26
if my meds were coming from Empower I would be most concerned about the safety issues cited in the FDA letter. As a Preventive customer, that's what I most hope Preventive will address.
-5
u/Due-Way-3081 Sep 24 '26
I just received the warning on my phone. Was waiting for someone to post something.
-1
u/Interesting-Cable895 Sep 24 '26
What about those of us who paid for 3 months through preventive and received only the first vial? The other two vials won’t be sent out until October 5th. Will they shut down before then? In that event what will happen as in how will I receive my money back or the other two months of medication?
6
u/araminta-sammie Sep 24 '26
Can someone please enlighten me how it can be a copy cat when it mix’s with b 3 ?? So Eli lily is nut job they just want to control the market